Lista de obras -

Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis

artículo científico publicado en 2015

Avoiding Overtreatment of Ductal Carcinoma in situ

artículo científico publicado en 2019

Breast adipocyte size associates with ipsilateral invasive breast cancer risk after ductal carcinoma in situ

artículo científico publicado en 2021

Breast cancer subtyping by immunohistochemistry and histological grade outperforms breast cancer intrinsic subtypes in predicting neoadjuvant chemotherapy response ⬇️

artículo científico publicado el 5 de julio de 2013

Clinicopathological Risk Factors for an Invasive Breast Cancer Recurrence after Ductal Carcinoma In Situ-A Nested Case-Control Study

artículo científico publicado en 2018

Comprehensive characterization of pre- and post-treatment samples of breast cancer reveal potential mechanisms of chemotherapy resistance

artículo científico publicado en 2022

Distribution pattern of the Ki67 labelling index in breast cancer and its implications for choosing cut-off values.

artículo científico publicado en 2014

EZH2 Is Overexpressed in -like Breast Tumors and Predictive for Sensitivity to High-Dose Platinum-Based Chemotherapy

artículo científico publicado en 2019

Early Assessment of Axillary Response with 18F-FDG PET/CT during Neoadjuvant Chemotherapy in Stage II–III Breast Cancer: Implications for Surgical Management of the Axilla ⬇️

artículo científico publicado el 1 de marzo de 2013

Effect of bile absorption coefficients on the estimation of liver tissue optical properties and related implications in discriminating healthy and tumorous samples ⬇️

artículo científico publicado el 15 de febrero de 2011

Endonuclease FEN1 coregulates ERα activity and provides a novel drug interface in tamoxifen resistant breast cancer

scientific article published on 19 March 2020

FDG PET/CT during neoadjuvant chemotherapy may predict response in ER-positive/HER2-negative and triple negative, but not in HER2-positive breast cancer ⬇️

artículo científico publicado el 12 de febrero de 2013

Genetic predisposition to ductal carcinoma in situ of the breast

artículo científico publicado en 2016

Genetic predisposition to in situ and invasive lobular carcinoma of the breast

artículo científico publicado en 2014

Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancer

artículo científico publicado en 2022

Genomic signature of BRCA1 deficiency in sporadic basal‐like breast tumors ⬇️

artículo científico publicado el 1 de febrero de 2011

Guiding Breast-Conserving Surgery in Patients After Neoadjuvant Systemic Therapy for Breast Cancer: A Comparison of Radioactive Seed Localization with the ROLL Technique ⬇️

artículo científico publicado el 6 de marzo de 2013

HER2 gene amplification in patients with breast cancer with equivocal IHC results ⬇️

artículo científico publicado el 11 de agosto de 2011

IHC-based Ki67 as response biomarker to tamoxifen in breast cancer window trials enrolling premenopausal women

artículo científico publicado en 2021

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

artículo científico publicado en 2017

Indicators of homologous recombination deficiency in breast cancer and association with response to neoadjuvant chemotherapy ⬇️

artículo científico publicado el 11 de octubre de 2010

MRI of the breast in patients with DCIS to exclude the presence of invasive disease ⬇️

artículo científico publicado el 26 de febrero de 2012

Neoadjuvant chemotherapy in ER+ HER2− breast cancer: response prediction based on immunohistochemical and molecular characteristics ⬇️

artículo científico publicado el 7 de abril de 2011

Nodal-Stage Classification in Invasive Lobular Breast Carcinoma: Influence of Different Interpretations of the pTNM Classification

artículo científico publicado en 2010

Optical sensing for tumor detection in the liver ⬇️

artículo científico publicado el 7 de septiembre de 2012

Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium

artículo científico publicado en 2014

Pre-treatment imaging and pathology characteristics of invasive breast cancers of limited extent: Potential relevance for MRI-guided localized therapy ⬇️

artículo científico publicado el 29 de mayo de 2012

Predictors of an Invasive Breast Cancer Recurrence after DCIS: A Systematic Review and Meta-analyses

scientific article published on 25 April 2019

Prognostic Value of Residual Disease after Neoadjuvant Therapy in HER2-Positive Breast Cancer Evaluated by Residual Cancer Burden, Neoadjuvant Response Index, and Neo-Bioscore

scientific article published on 10 May 2019

Prognostic value of histopathological DCIS features in a large-scale international interrater reliability study

artículo científico publicado en 2020

Quantitative copy number analysis by Multiplex Ligation-dependent Probe Amplification (MLPA) of BRCA1-associated breast cancer regions identifies BRCAness ⬇️

artículo científico publicado el 27 de octubre de 2011

Radiogenomic Analysis of Breast Cancer by Linking MRI Phenotypes with Tumor Gene Expression

artículo científico publicado en 2020

Results of a worldwide survey on the currently used histopathological diagnostic criteria for invasive lobular breast cancer

artículo científico publicado en 2022

Sequential 18F-FDG PET/CT for early prediction of complete pathological response in breast and axilla during neoadjuvant chemotherapy ⬇️

artículo científico publicado el 9 de agosto de 2013

Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies

artículo científico publicado en 2010

Triple-negative breast cancer: BRCAness and concordance of clinical features with BRCA1-mutation carriers ⬇️

artículo científico publicado el 4 de abril de 2013

Tumor-type specific intracellular bacteria are undetectable in human breast cancer cells ⬇️

2023 eLetter in Science by de Miranda et al

Lista de obras de

Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis

Avoiding Overtreatment of Ductal Carcinoma in situ

Breast adipocyte size associates with ipsilateral invasive breast cancer risk after ductal carcinoma in situ

Breast cancer subtyping by immunohistochemistry and histological grade outperforms breast cancer intrinsic subtypes in predicting neoadjuvant chemotherapy response ⬇️

Clinicopathological Risk Factors for an Invasive Breast Cancer Recurrence after Ductal Carcinoma In Situ-A Nested Case-Control Study

Comprehensive characterization of pre- and post-treatment samples of breast cancer reveal potential mechanisms of chemotherapy resistance

Distribution pattern of the Ki67 labelling index in breast cancer and its implications for choosing cut-off values.

EZH2 Is Overexpressed in -like Breast Tumors and Predictive for Sensitivity to High-Dose Platinum-Based Chemotherapy

Early Assessment of Axillary Response with 18F-FDG PET/CT during Neoadjuvant Chemotherapy in Stage II–III Breast Cancer: Implications for Surgical Management of the Axilla ⬇️

Effect of bile absorption coefficients on the estimation of liver tissue optical properties and related implications in discriminating healthy and tumorous samples ⬇️

Endonuclease FEN1 coregulates ERα activity and provides a novel drug interface in tamoxifen resistant breast cancer

FDG PET/CT during neoadjuvant chemotherapy may predict response in ER-positive/HER2-negative and triple negative, but not in HER2-positive breast cancer ⬇️

Genetic predisposition to ductal carcinoma in situ of the breast

Genetic predisposition to in situ and invasive lobular carcinoma of the breast

Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancer

Genomic signature of BRCA1 deficiency in sporadic basal‐like breast tumors ⬇️

Guiding Breast-Conserving Surgery in Patients After Neoadjuvant Systemic Therapy for Breast Cancer: A Comparison of Radioactive Seed Localization with the ROLL Technique ⬇️

HER2 gene amplification in patients with breast cancer with equivocal IHC results ⬇️

IHC-based Ki67 as response biomarker to tamoxifen in breast cancer window trials enrolling premenopausal women

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

Indicators of homologous recombination deficiency in breast cancer and association with response to neoadjuvant chemotherapy ⬇️

MRI of the breast in patients with DCIS to exclude the presence of invasive disease ⬇️

Neoadjuvant chemotherapy in ER+ HER2− breast cancer: response prediction based on immunohistochemical and molecular characteristics ⬇️

Nodal-Stage Classification in Invasive Lobular Breast Carcinoma: Influence of Different Interpretations of the pTNM Classification

Optical sensing for tumor detection in the liver ⬇️

Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium

Pre-treatment imaging and pathology characteristics of invasive breast cancers of limited extent: Potential relevance for MRI-guided localized therapy ⬇️

Predictors of an Invasive Breast Cancer Recurrence after DCIS: A Systematic Review and Meta-analyses

Prognostic Value of Residual Disease after Neoadjuvant Therapy in HER2-Positive Breast Cancer Evaluated by Residual Cancer Burden, Neoadjuvant Response Index, and Neo-Bioscore

Prognostic value of histopathological DCIS features in a large-scale international interrater reliability study

Quantitative copy number analysis by Multiplex Ligation-dependent Probe Amplification (MLPA) of BRCA1-associated breast cancer regions identifies BRCAness ⬇️

Radiogenomic Analysis of Breast Cancer by Linking MRI Phenotypes with Tumor Gene Expression

Results of a worldwide survey on the currently used histopathological diagnostic criteria for invasive lobular breast cancer

Sequential 18F-FDG PET/CT for early prediction of complete pathological response in breast and axilla during neoadjuvant chemotherapy ⬇️

Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies

Triple-negative breast cancer: BRCAness and concordance of clinical features with BRCA1-mutation carriers ⬇️

Tumor-type specific intracellular bacteria are undetectable in human breast cancer cells ⬇️